Mason Morfit ValueAct Holdings
Mason Morfit is chief executive officer of ValueAct Capital, a major constructive-activist investment firm. ValueAct typically takes significant stakes in companies and works with boards on strategy, capital allocation, and operational improvement. Morfit’s campaigns and holdings are closely watched in both activist and fundamental investing communities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$881M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$438M |
| 3 |
AGU
Agrium
AGU
|
+$215M |
| 4 |
Halliburton
HAL
|
+$173M |
| 5 |
CBRE Group
CBRE
|
+$196K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$973M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$120M |
| 3 |
WCC
WESCO International
WCC
|
+$74.4M |
| 4 |
Adobe
ADBE
|
+$23.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.51% |
| 2 | Healthcare | 17.54% |
| 3 | Energy | 16.06% |
| 4 | Financials | 12.11% |
| 5 | Communication Services | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bausch Health
BHC
$2.41B
| $3.33B | 17.54% |
14,994,261
-4,389,616
| -23% | -$973M |
|
2
Microsoft
MSFT
$3.59T
| $3.32B | 17.5% |
75,271,429
| – | – |
|
|
3
Halliburton
HAL
$29.4B
| $1.62B | 8.51% |
37,518,260
+3,761,500
| +11% | +$173M |
|
|
TFCF
4
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $1.44B | 7.56% |
44,581,334
+13,196,334
| +42% | +$438M |
|
|
BHI
5
DELISTED
Baker Hughes
BHI
| $1.43B | 7.55% |
23,246,700
| – | – |
|
|
6
Adobe
ADBE
$109B
| $1.27B | 6.7% |
15,703,739
-303,014
| -2% | -$23.6M |
|
|
7
CBRE Group
CBRE
$44B
| $1.16B | 6.1% |
31,327,405
+5,175
| +0% | +$196K |
|
|
AGU
8
DELISTED
Agrium
AGU
| $1.06B | 5.58% |
10,003,451
+2,040,446
| +26% | +$215M |
|
9
Motorola Solutions
MSI
$79.5B
| $1.01B | 5.31% |
17,588,576
| – | – |
|
10
Willis Towers Watson
WTW
$31.8B
| $864M | 4.55% |
6,954,998
| – | – |
|
|
11
American Express
AXP
$227B
| $863M | 4.54% |
+11,100,000
| New | +$881M |
|
12
MSCI
MSCI
$41B
| $573M | 3.02% |
9,308,960
| – | – |
|
13
Allison Transmission
ALSN
$11B
| $560M | 2.95% |
19,125,204
| – | – |
|
14
Armstrong World Industries
AWI
$7.55B
| $490M | 2.58% |
9,200,000
| – | – |
|
|
WCC
15
WESCO International
WCC
$17B
| – | – |
-1,064,800
| Closed | -$74.4M |
|
|
PCP
16
DELISTED
PRECISION CASTPARTS CORP
PCP
| – | – |
-569,185
| Closed | -$120M |
|
Similar funds
Mason Morfit's Q2 2015 Portfolio in Review
As of Q2 2015, Mason Morfit held 16 positions worth $19B, up 5% from $18.1B the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Mason Morfit's Q2 2015 filing shows 1 new, 4 increased, 2 reduced and 2 closed positions. Its largest new stake was American Express: 11,100,000 shares worth $863M. The largest sale was Bausch Health, an estimated $973M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Energy.
- Mason Morfit's largest Q2 2015 buy was American Express: 11,100,000 shares worth $863M.
- Mason Morfit added most to Twenty-First Century Fox, Inc. Class B in Q2 2015, an estimated $438M increase.
- Mason Morfit's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $973M.
- Mason Morfit fully exited PRECISION CASTPARTS CORP in Q2 2015, selling an estimated $120M.
- Mason Morfit's ten largest holdings make up 87% of its $19B portfolio in Q2 2015.
- Mason Morfit opened 1 new position and closed 2 in Q2 2015.
- Mason Morfit's portfolio value rose 5% quarter-over-quarter to $19B.
Based on ValueAct Holdings's 13F filing for Q2 2015, filed 17 Aug 2015.